| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038714804 |
| P356 | DOI | 10.1023/A:1021635223370 |
| P698 | PubMed publication ID | 10857252 |
| P50 | author | Michael Lyons | Q42702014 |
| Stephen Faraone | Q7609174 | ||
| P2093 | author name string | J Goldberg | |
| W R True | |||
| M T Tsuang | |||
| H Xian | |||
| S Eisen | |||
| R M Harley | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 473-479 | |
| P577 | publication date | 1999-11-01 | |
| P1433 | published in | Behavior Genetics | Q4034967 |
| P1476 | title | Genetic and environmental influences on transitions in drug use | |
| P478 | volume | 29 |
| Q33562500 | A cotwin-control analysis of drug use and abuse/dependence risk associated with early-onset cannabis use |
| Q35978365 | A cultural psychology approach to "drug abuse" prevention |
| Q33585794 | Cannabis dependence in the San Francisco Family Study: age of onset of use, DSM-IV symptoms, withdrawal, and heritability |
| Q34875333 | Chronic stress, drug use, and vulnerability to addiction |
| Q33625523 | Cocaine abuse versus cocaine dependence: cocaine self-administration and pharmacodynamic response in the human laboratory |
| Q34546657 | Common genetic influences on the timing of first use for alcohol, cigarettes, and cannabis in young African-American women |
| Q33641858 | Comparing the dynamic course of heroin, cocaine, and methamphetamine use over 10 years |
| Q92205726 | Contributions of social influences and psychopathological factors to cannabis use and dependence in high-school students |
| Q30496229 | Dose preference and dose escalation in extended-access cocaine self-administration in Fischer and Lewis rats |
| Q46616121 | Effects of the serotonin transporter (5-HTTLPR) and α2A-adrenoceptor (C-1291G) genotypes on substance use in children and adolescents: a longitudinal study |
| Q36493558 | Evidence for a two-stage model of dependence using the NESARC and its implications for genetic association studies. |
| Q35950888 | Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability |
| Q33805566 | Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies |
| Q34463235 | Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction |
| Q47863987 | Genetic moderation of cocaine subjective effects by variation in the TPH1, TPH2, and SLC6A4 serotonin genes |
| Q30988864 | Genetic studies of pathological gambling: a review of methodology and analyses of data from the Vietnam Era Twin Registry |
| Q30491913 | Genetically correlated effects of selective breeding for high and low methamphetamine consumption. |
| Q34139876 | Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence |
| Q34555160 | Linkage disequilibrium, haplotype and association studies of a chromosome 4 GABA receptor gene cluster: candidate gene variants for addictions |
| Q34626430 | Marijuana use among adolescents |
| Q33750905 | Modeling the genetic and environmental association between peer group deviance and cannabis use in male twins |
| Q36525149 | Molecular genetics of addiction vulnerability |
| Q52106171 | Needed: mouse/human cross validation of reinstatement/relapse models (and drug reward models) to model human substance abuse vulnerability allelic variants. |
| Q36335668 | Neuroplasticity, axonal guidance and micro-RNA genes are associated with morphine self-administration behavior |
| Q28269117 | NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice |
| Q33719240 | Observational study to calculate addictive risk to opioids: a validation study of a predictive algorithm to evaluate opioid use disorder |
| Q33750925 | Pathways to cannabis abuse: a multi-stage model from cannabis availability, cannabis initiation and progression to abuse |
| Q34116570 | Pharmacogenomics and addiction to opiates |
| Q24535898 | Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms |
| Q37579911 | Pooled association genome scanning for alcohol dependence using 104,268 SNPs: validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism |
| Q33383362 | Predicting treatment outcome in stimulant dependence |
| Q36626237 | Prevalence and correlates of dual diagnoses in U.S. Latinos |
| Q37375052 | Rate of progression from first use to dependence on cocaine or opioids: a cross-substance examination of associated demographic, psychiatric, and childhood risk factors |
| Q30707290 | Substance abuse vulnerability loci: converging genome scanning data |
| Q44334539 | The association between prescribed opioid use for mothers and children: a record-linkage study |
| Q28477546 | The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors |
| Q38805460 | The relationship between initial route of heroin administration and speed of transition to daily heroin use. |
| Q41544475 | Validation Study of a Predictive Algorithm to Evaluate Opioid Use Disorder in a Primary Care Setting |
| Q35195505 | What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction? |
Search more.